Annual Scientific Meeting

Treat-to-Target 2019: Is It Really the Target or the Process?

Speaker(s)

• 

  Edward Loftus, Jr., MD, FACG

  Professor of Medicine
  Division of Gastroenterology and Hepatology, Mayo Clinic
  Rochester, MN, US

  Advisory Committee/Board Member: AbbVie, UCB
  Consultant: Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Ltd., Eli Lilly, Genentech, Gilead, Janssen, Pfizer, Takeda
  Grant/Research Support: AbbVie, Amgen, Celgene, Genentech, Gilead, Janssen, MedImmune, Pfizer, Robarts Clinical Trials, Seres Therapeutics, Takeda, UCB
  Editor: SLACK Inc./Healio Gastroenterology

Learning Objectives:

• Identify the right target for the right patient based on patient and disease-related risk factors.